Diabetes and weight-loss drug tirzepatide (Mounjaro, Zepbound) was listed as a contributing factor in the death of a 58-year-old nurse from Scotland who died of multiple organ failure, septic shock, ...

NBC News medical contributor Dr. Natalie Azar joins TODAY to discuss the three types of diabetes, the risk factors for each ...

Descriptive epidemiology is important for understanding causes, evaluating potential effects of policies and environmental ...

Use of these drugs can improve diabetes management without increasing risk for hypoglycemia ... Highlights of this newly ...

SGLT2 inhibitors and GLP-1 receptor agonists exhibit renoprotective effects in patients with CKD with and without diabetes.

Type 1 diabetes (also known as diabetes mellitus) is an autoimmune disease in which immune cells attack and destroy the insulin-producing cells of the pancreas. The loss of insulin leads to the ...

Use of sodium glucose cotransporter 2 (SGLT-2) inhibitor drugs to treat type 2 diabetes may also help to lower the risk of ...

While treatment may be able to prevent damage to the retina before this occurs, once it happens, it cannot be undone, and any related vision loss is permanent. If you have any form of diabetes, you ...

damkaz/Getty Images Those people who were using semaglutide had a lower risk of being diagnosed with Alzheimer’s disease than those using other diabetes drugs. The Alzheimer’s Association ...

Advocates for diabetes patients who need insulin to survive worry the nation's supply is unreliable. Meanwhile, use of ...

The results add to mounting evidence that GLP-1s, a popular class of obesity and diabetes medications, may offer health benefits beyond promoting weight loss and regulating blood sugar.